Coenzyme Q10 (Co-Q10), a lipid-soluble quinone cofactor participating in both mitochondrial bioenergetics and antioxidant defense, represents one of the most extensively characterized bioactive nutrients in clinical nutrition science.

Within the Three-Axis, Seven-Module Framework proposed by Keyora, Co-Q10’s functions are systematically reinterpreted as a multi-dimensional network integrating energy metabolism, redox regulation, cardiovascular protection, neuroprotection, and anti-aging.

Axis I – Mitochondrial Energy Axis:

Delineates Co-Q10 as the central electron carrier between Complexes I/II and III in the electron transport chain, sustaining ATP synthesis and maintaining the proton motive force.

Human RCTs (e.g., Q-SYMBIO, KISEL-10) confirm its ability to enhance myocardial contractility, improve exercise tolerance, and reduce cardiovascular events.
In athletes and chronic fatigue patients,

supplementation (100-300 mg/day) increases VO₂max, accelerates lactate clearance, and alleviates fatigue, while aging cohorts demonstrate improved vitality and reduced functional decline through restored mitochondrial efficiency.

Axis II – Antioxidant and Cellular Protection Axis:

Emphasizes Co-Q10’s redox cycling (ubiquinone ↔ ubiquinol) as the basis for sustained free radical scavenging and regeneration of vitamin E/C.

This antioxidant loop mitigates oxidative injury, preserves endothelial function, and prevents inflammatory remodeling, thereby supporting cardiovascular and cellular homeostasis.

Synergistic interactions with selenium and other micronutrients (as evidenced in the KISEL-10 study) amplify both antioxidant and cardio-protective effects.

Axis III – Disease Intervention and Anti-Aging Axis:

Extends Co-Q10’s implications to pathological and aesthetic medicine.

In neurological disorders (Parkinson’s, Alzheimer’s, migraine), Co-Q10 preserves neuronal mitochondria and dopaminergic integrity.

In statin-associated myopathy, it replenishes depleted stores, mitigating muscle symptoms.

In dermatological and anti-aging contexts, oral (100–200 mg/day) and topical Co-Q10 enhance dermal ATP supply, reduce MMP-mediated collagen degradation, and improve elasticity, hydration, and wrinkle parameters in controlled clinical trials.

Collectively, the evidence positions Co-Q10 as a dual-function molecular hub bridging energy production and redox equilibrium. Across cardiovascular, neurological, muscular, and dermatological systems, it exhibits robust translational efficacy, excellent safety, and long-term tolerability.

The Three-Axis, Seven-Module Framework provides a unifying model for understanding its systemic bioactivity, clinical applicability, and integration into preventive, therapeutic, and anti-aging strategies.